Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model

Overview of attention for article published in Frontiers in immunology, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 56 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 21,590 followers.

Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model. https://t.co/9fRAB7cgks

24 Nov 2020

Reply Repost Favourite

RT @arturoreyess: Can a vaccine offer cross protection at once to #Mayaro and #Chikungunya viruses? #Adenoviral-Vectored #Mayaro and #Chiku…

12 Nov 2020

Reply Repost Favourite

RT @iuis_online: Last weeks #Top5 #viewed @Frontiersin. Pre-clinical study demonstrates the cross-reactive heterologous protection of Adeno…

11 Nov 2020

Reply Repost Favourite

Last weeks #Top5 #viewed @Frontiersin. Pre-clinical study demonstrates the cross-reactive heterologous protection of Adenoviral-Vectored mayaro and chikungunya virus #vaccine candidates against both #vector-borne viruses. more @ https://t.co/cEfOLTQsxK

11 Nov 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.